PMGC (NASDAQ:ELAB) Announces Quarterly Earnings Results

PMGC (NASDAQ:ELABGet Free Report) released its earnings results on Thursday. The company reported ($11.22) earnings per share (EPS) for the quarter, FiscalAI reports. The company had revenue of $0.68 million for the quarter.

PMGC Trading Up 1.0%

NASDAQ ELAB traded up $0.02 on Friday, hitting $2.08. The company’s stock had a trading volume of 1,622,509 shares, compared to its average volume of 1,436,766. The company’s 50-day simple moving average is $3.70 and its 200 day simple moving average is $41.87. PMGC has a 52-week low of $1.62 and a 52-week high of $309.12. The company has a current ratio of 1.74, a quick ratio of 1.72 and a debt-to-equity ratio of 0.01. The firm has a market cap of $2.41 million, a P/E ratio of -0.01 and a beta of -0.27.

About PMGC

(Get Free Report)

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.

Recommended Stories

Earnings History for PMGC (NASDAQ:ELAB)

Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.